GOG-3066 ZN-c3-005 platinum resistant ovarian cancer

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Subjects with High-Grade Serous Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer
Principal Investigator
Professor of Obstetrics and Gynecology
Protocol Number
IRB: PRO00110517
NCT: NCT05128825
Phase
Phase II
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL